Taxanes in the elderly patient with metastatic breast cancer [Corrigendum]
Yardley DA. Breast Cancer Targets Therapy. 2015:7;293–301.On page 300, Disclosure section, “The author reports no conflicts of interest in the work” has been updated since publication and should read “Dr Yardley reports nonfinancial support from Celgene pertai...
Guardado en:
Autor principal: | Yardley DA |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b58e87eb8d3547e6b2991eacd2d9bdeb |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Taxanes in the elderly patient with metastatic breast cancer
por: Yardley DA
Publicado: (2015) -
A Retrospective Analysis of the Effect of Irinotecan-Based Regimens in Patients With Metastatic Breast Cancer Previously Treated With Anthracyclines and Taxanes
por: Jiaojiao Suo, et al.
Publicado: (2021) -
Glembatumumab vedotin for patients with metastatic, gpNMB overexpressing, triple-negative breast cancer (“METRIC”): a randomized multicenter study
por: Linda T. Vahdat, et al.
Publicado: (2021) -
Trastuzumab emtansine in the treatment of HER2-positive metastatic breast cancer in Japanese patients
por: Sawaki M
Publicado: (2014) -
Comprehensive characterization of distinct genetic alterations in metastatic breast cancer across various metastatic sites
por: Soojin Cha, et al.
Publicado: (2021)